Alpine Partners VI LLC 13D and 13G filings for Immunome, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 2:10 pm Sale |
2023-12-31 | 13G | Immunome, Inc. IMNM |
Alpine Partners VI LLC | 192,333 0.450% |
-525,902 (-73.22%) |
Filing |
| 2023-01-17 12:04 pm Sale |
2022-12-31 | 13G | Immunome, Inc. IMNM |
Alpine Partners VI LLC | 718,235 5.900% |
-143,936 (-16.69%) |
Filing |
| 2022-01-14 4:58 pm Purchase |
2021-12-31 | 13G | Immunome, Inc. IMNM |
Alpine Partners VI LLC | 862,171 7.100% |
72,462 (+9.18%) |
Filing |
| 2021-02-24 3:57 pm Sale |
2020-12-31 | 13G | Immunome, Inc. IMNM |
Alpine Partners VI LLC | 789,709 7.500% |
-499 (-0.06%) |
Filing |
| 2021-01-13 3:08 pm Purchase |
2020-12-31 | 13G | Immunome, Inc. IMNM |
Alpine Partners VI LLC | 790,208 7.500% |
790,208 (New Position) |
Filing |
| 2020-10-08 11:23 am Purchase |
2020-10-08 | 13G | Immunome, Inc. IMNM |
Alpine Partners VI LLC | 791,666 7.890% |
791,666 (New Position) |
Filing |